Dexco Performance degli utili passati
Criteri Il passato verificati 0/6
Gli utili di Dexco sono diminuiti a un tasso medio annuo di -49.5%, mentre il settore Forestry ha visto gli utili diminuire a un tasso medio annuo di 4.1%. I ricavi sono cresciuti crescere a un tasso medio annuo di 0.5%.
Informazioni chiave
-49.46%
Tasso di crescita degli utili
-50.26%
Tasso di crescita dell'EPS
| Forestry Crescita del settore | 45.90% |
| Tasso di crescita dei ricavi | 0.48% |
| Rendimento del capitale proprio | 0.71% |
| Margine netto | -0.11% |
| Prossimo aggiornamento sugli utili | 04 Nov 2026 |
Aggiornamenti sulle prestazioni recenti
Articolo di analisi • May 18
Dexco's (BVMF:DXCO3) Weak Earnings May Only Reveal A Part Of The Whole Picture
Dexco S.A.'s ( BVMF:DXCO3 ) stock showed strength, with investors undeterred by its weak earnings report. We think that...Articolo di analisi • Nov 13
Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. We think that...Recent updates
Aggiornamento narrativa • Jun 16
DXCO3: Board Refresh And Margin Outlook Will Support Future Upside
Analysts have maintained their R$9.00 price target for Dexco, noting only minor changes to assumptions for discount rate, revenue growth, profit margin and future P/E that do not materially change their view of the stock. What's in the News Dexco has scheduled a Board Meeting for May 4, 2026, at 12:00 Coordinated Universal Time.Aggiornamento narrativa • Jun 01
DXCO3: Higher Margin Outlook And Governance Reset Will Support Upside
Analysts have adjusted their R$ price target for Dexco, citing updated assumptions for discount rate, revenue growth, profit margin, and future P/E that keep fair value around R$9,00 while refining the risk and earnings profile behind that estimate. What's in the News Dexco has scheduled a Board Meeting for May 4, 2026, at 12:00 UTC, focused on board and executive appointments.Articolo di analisi • May 18
Dexco's (BVMF:DXCO3) Weak Earnings May Only Reveal A Part Of The Whole Picture
Dexco S.A.'s ( BVMF:DXCO3 ) stock showed strength, with investors undeterred by its weak earnings report. We think that...
Aggiornamento narrativa • May 02
DXCO3: Future Stock Split Will Support More Attractive Multiple Repricing Outlook
Analysts have raised their price target on Dexco from approximately R$7.16 to about R$7.28, citing updated assumptions regarding the discount rate, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value: R$7.16 to R$7.28, representing a small upward adjustment in the modelled target price range.Aggiornamento narrativa • Apr 18
DXCO3: Higher Revenue Outlook And Richer Future P/E Will Support Upside
Analysts have raised their valuation of Dexco, increasing the fair value estimate from R$8.70 to R$9.00. The change reflects updated assumptions that include higher revenue growth expectations, a lower discount rate and a richer future P/E multiple, partly offset by a lower projected profit margin.Aggiornamento narrativa • Apr 04
DXCO3: Future Stock Split Will Support A More Attractive Repricing Outlook
Analysts have slightly adjusted their R$ price target on Dexco, citing updated assumptions that combine a different fair value estimate with changes to revenue growth, profit margin expectations and a higher future P/E multiple. Valuation Changes Fair Value: R$7.22 in the previous model compared with R$7.16 in the updated assumptions.
Aggiornamento narrativa • Mar 21
DXCO3: Planned Stock Split And Margin Outlook Will Support Future Upside
Analysts have kept their R$ fair value estimate for Dexco steady at R$5.36. Updated assumptions reflect a slightly higher discount rate, a marginally lower revenue growth outlook, a modestly stronger profit margin, and a similar future P/E expectation.Aggiornamento narrativa • Mar 06
DXCO3: Planned Stock Split Will Support Positive Long Term Outlook
Analysts have revised their R$ price target for Dexco slightly, with the change grounded in updated assumptions that include a different discount rate, adjusted revenue growth and profit margin expectations, and a revised future P/E multiple. What's in the News Dexco plans a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).Aggiornamento narrativa • Feb 20
DXCO3: Future Stock Split Will Support A More Attractive Share Repricing
Analysts have trimmed their R$ price target for Dexco, reflecting a slightly lower fair value estimate alongside updated assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News Dexco announced a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).Aggiornamento narrativa • Feb 06
DXCO3: Stock Split And Conservative Earnings Profile Will Support Future Upside
Analysts have reduced their fair value estimate for Dexco from about $8.81 to $8.70 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E, which collectively indicate a more conservative earnings profile than previously estimated.Aggiornamento narrativa • Jan 23
DXCO3: Future Split And Revised Assumptions Will Shape Balanced Outlook
Analysts have reduced their fair value estimate for Dexco from US$6.00 to US$5.36, citing updated assumptions for revenue growth, profit margins, the discount rate, and a lower future P/E multiple. What's in the News Dexco has announced a stock split or significant stock dividend with a 1.12 to 1 ratio, scheduled for December 26, 2025 (Key Developments).Articolo di analisi • Jan 23
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Aggiornamento narrativa • Jan 08
DXCO3: Future Margins And Stock Split Plan Will Support Upside
Analysts have adjusted their price target for Dexco, reflecting a fair value change from $9.83 to $8.81. This shift is tied to updated assumptions for revenue growth, profit margins and future P/E expectations.Articolo di analisi • Dec 25
Dexco S.A. (BVMF:DXCO3) Not Flying Under The Radar
With a price-to-earnings (or "P/E") ratio of 41.1x Dexco S.A. ( BVMF:DXCO3 ) may be sending very bearish signals at the...Aggiornamento narrativa • Dec 23
DXCO3: Stronger Future Margins And Investor Day May Drive Upside
Analysts have adjusted their price target on Dexco from R$10.00 to roughly R$9.83 per share. This reflects slightly lower revenue growth assumptions, stronger expected profit margins, and a more conservative future valuation multiple.Articolo di analisi • Nov 13
Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. We think that...Articolo di analisi • Oct 06
Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Aggiornamento narrativa • Sep 06
Urbanization Trends And Digital Platforms Will Expand Market Reach
With both revenue growth and net profit margin forecasts holding steady, Dexco’s analyst consensus fair value remains unchanged at R$8.00. Valuation Changes Summary of Valuation Changes for Dexco The Consensus Analyst Price Target remained effectively unchanged, at R$8.00.Articolo di analisi • Mar 21
Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. Our analysis...Articolo di analisi • Mar 15
Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Shareholders might have noticed that Dexco S.A. ( BVMF:DXCO3 ) filed its full-year result this time last week. The...
Nuova narrativa • Mar 10
New Ceramic Tiles Factory In Botucatu Will Improve Future Operations
Streamlining of operations could enhance focus on core areas, boosting profitability and improving net margins.Articolo di analisi • Feb 12
Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Articolo di analisi • Dec 20
Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?
While Dexco S.A. ( BVMF:DXCO3 ) might not have the largest market cap around , it saw significant share price movement...Articolo di analisi • Dec 02
There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price
When close to half the companies in Brazil have price-to-earnings ratios (or "P/E's") below 8x, you may consider Dexco...Articolo di analisi • Oct 26
Is Dexco (BVMF:DXCO3) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Articolo di analisi • Aug 10
Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results
Shareholders of Dexco S.A. ( BVMF:DXCO3 ) will be pleased this week, given that the stock price is up 12% to R$8.05...Articolo di analisi • Aug 08
Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a decent share price growth of 14% on the...Articolo di analisi • Jul 19
Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Articolo di analisi • May 13
Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts
Last week saw the newest quarterly earnings release from Dexco S.A. ( BVMF:DXCO3 ), an important milestone in the...Articolo di analisi • May 04
Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a double-digit share price rise of over 10...Articolo di analisi • Apr 15
Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Articolo di analisi • Mar 14
Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem
Shareholders didn't seem to be thrilled with Dexco S.A.'s ( BVMF:DXCO3 ) recent earnings report, despite healthy profit...Articolo di analisi • Jan 19
Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors
With a price-to-earnings (or "P/E") ratio of 7.5x Dexco S.A. ( BVMF:DXCO3 ) may be sending bullish signals at the...Articolo di analisi • Jan 04
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Articolo di analisi • Dec 04
At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?
Dexco S.A. ( BVMF:DXCO3 ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...Articolo di analisi • Oct 08
Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Ripartizione dei ricavi e delle spese
Ripartizione dei ricavi e delle spese
Come Dexco guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storico di utili e ricavi
| Data | Ricavi | Utili | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 30 Jun 26 | 8,475 | -9 | 1,517 | 0 |
| 31 Mar 26 | 8,365 | 9 | 1,516 | 0 |
| 31 Dec 25 | 8,249 | 1 | 1,530 | 0 |
| 30 Sep 25 | 8,216 | 111 | 1,530 | 0 |
| 30 Jun 25 | 8,327 | 193 | 1,581 | 0 |
| 31 Mar 25 | 8,201 | 258 | 1,563 | 0 |
| 31 Dec 24 | 8,235 | 172 | 1,545 | 0 |
| 30 Sep 24 | 8,119 | 337 | 1,533 | 0 |
| 30 Jun 24 | 7,649 | 542 | 1,471 | 0 |
| 31 Mar 24 | 7,607 | 602 | 1,475 | 0 |
| 31 Dec 23 | 7,383 | 790 | 1,428 | 0 |
| 30 Sep 23 | 7,415 | 812 | 1,381 | 0 |
| 30 Jun 23 | 7,808 | 668 | 1,392 | 0 |
| 31 Mar 23 | 8,068 | 680 | 1,415 | 0 |
| 31 Dec 22 | 8,487 | 756 | 1,459 | 0 |
| 30 Sep 22 | 8,757 | 1,128 | 1,492 | 0 |
| 30 Jun 22 | 8,773 | 1,229 | 1,446 | 0 |
| 31 Mar 22 | 8,533 | 1,776 | 1,337 | 0 |
| 31 Dec 21 | 8,170 | 1,725 | 1,310 | 0 |
| 30 Sep 21 | 7,813 | 1,446 | 1,164 | 0 |
| 30 Jun 21 | 7,414 | 1,315 | 1,127 | 0 |
| 31 Mar 21 | 6,486 | 574 | 1,065 | 0 |
| 31 Dec 20 | 5,880 | 454 | 1,037 | 0 |
| 30 Sep 20 | 5,472 | 437 | 1,018 | 0 |
| 30 Jun 20 | 5,003 | 341 | 990 | 0 |
| 31 Mar 20 | 5,101 | 434 | 980 | 0 |
| 31 Dec 19 | 5,012 | 406 | 948 | 0 |
| 30 Sep 19 | 4,789 | -21 | 919 | 0 |
| 30 Jun 19 | 4,993 | 327 | 929 | 0 |
| 31 Mar 19 | 5,016 | 425 | 919 | 0 |
| 31 Dec 18 | 4,949 | 432 | 899 | 0 |
| 30 Sep 18 | 4,789 | 658 | 869 | 0 |
| 30 Jun 18 | 4,296 | 365 | 825 | 0 |
| 31 Mar 18 | 4,045 | 223 | 807 | 0 |
| 31 Dec 17 | 3,991 | 185 | 801 | 0 |
| 30 Sep 17 | 3,917 | 125 | 785 | 0 |
| 30 Jun 17 | 3,864 | 72 | 761 | 0 |
| 31 Mar 17 | 3,960 | 47 | 761 | 0 |
| 31 Dec 16 | 3,910 | 24 | 752 | 0 |
| 30 Sep 16 | 3,836 | 50 | 757 | 0 |
| 30 Jun 16 | 3,911 | 48 | 767 | 0 |
| 31 Mar 16 | 3,863 | 85 | 754 | 0 |
| 31 Dec 15 | 3,963 | 183 | 755 | 0 |
| 30 Sep 15 | 4,048 | 221 | 731 | 0 |
Guadagni di qualità: DXCO3 al momento non è redditizia.
Margine di profitto in crescita: DXCO3 al momento non è redditizia.
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: DXCO3 non è redditizia e le perdite sono aumentate negli ultimi 5 anni a un tasso pari a 49.5% all'anno.
Accelerare la crescita: Impossibile confrontare la crescita degli utili di DXCO3 nell'ultimo anno con la sua media quinquennale poiché al momento non è redditizia
Guadagni vs Settore: DXCO3 non è redditizia, il che rende difficile confrontare la crescita dei suoi utili dell'anno passato con il settore Forestry ( 3.5% ).
Rendimento del capitale proprio
ROE elevato: DXCO3 ha un Return on Equity negativo ( 0.71% ), in quanto al momento non è redditizio.
Rendimento delle attività
Rendimento del capitale investito
Scoprire le aziende con forti performance passate
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/08/21 06:25 |
| Prezzo dell'azione a fine giornata | 2026/08/20 00:00 |
| Utili | 2026/06/30 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Dexco S.A. è coperta da 15 analisti. 9 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Guilherme Rosito | BofA Global Research |
| Rafael Barcellos | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |
| Carlos Palhares Sequeira | BTG Pactual |